Skip to main content
Top
Published in:

01-06-2025 | Metabolic Dysfunction-Associated Steatotic Liver Disease | Research article

Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models

Authors: Tannaz Jamialahmadi, Mehdi Azizmohammad Looha, Sara Jangjoo, Nima Emami, Mohammed Altigani Abdalla, Mohammadreza Ganjali, Sepideh Salehabadi, Sercan Karav, Thozhukat Sathyapalan, Ali H. Eid, Ali Jangjoo, Amirhossein Sahebkar

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2025

Login to get access

Abstract

Objectives

Liver fibrosis resulting from nonalcoholic fatty liver disease (NAFLD) and metabolic disorders is highly prevalent in patients with severe obesity and poses a significant health challenge. However, there is a lack of data on the effectiveness of noninvasive factors in predicting liver fibrosis. Therefore, this study aimed to assess the relationship between these factors and liver fibrosis through a machine learning approach.

Methods

This study involved 512 patients who underwent bariatric surgery at an outpatient clinic in Mashhad, Iran, between December 2015 and September 2021. Patients were divided into fibrosis and non-fibrosis groups and demographic, clinical, and laboratory variables were applied to develop four machine learning models: Naive Bayes (NB), logistic regression (LR), Neural Network (NN) and Support Vector Machine (SVM),

Results

Among the 28 variables considered, six variables including (fasting blood sugar (FBS), skeletal muscle mass (SMM), hemoglobin, alanine transaminase (ALT), aspartate transaminase (AST) and triglycerides) showed high area under the curve (AUC) values for the diagnosis of liver fibrosis using 2D shear wave elastography (SWE) with LR (0.73, 95% CI: 0.65, 0.81) and SVM (0.72, 59% CI: 0.64, 0.80) models. Furthermore, the highest sensitivities were reported with SVM (0.83, 95% CI: 0.72, 0.91) and NB (0.66, 95% CI: 0.53, 0.77) models, respectively.

Conclusion

The predictive performance of six noninvasive factors of liver fibrosis was significantly superior to other factors, showing high application and accuracy in the diagnosis and prognosis of liver fibrosis.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Predictive performance of noninvasive factors for liver fibrosis in severe obesity: a screening based on machine learning models
Authors
Tannaz Jamialahmadi
Mehdi Azizmohammad Looha
Sara Jangjoo
Nima Emami
Mohammed Altigani Abdalla
Mohammadreza Ganjali
Sepideh Salehabadi
Sercan Karav
Thozhukat Sathyapalan
Ali H. Eid
Ali Jangjoo
Amirhossein Sahebkar
Publication date
01-06-2025
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2025
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-025-01564-1

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more